and Press

Sign up now for the latest IR news, and updates on ongoing developments at Avicanna Inc:

    Avicanna Executes Multi Year Agreement to Supply Brazilian Pharmaceutical Company with THC and CBD Cannabis Extracts
    Avicanna and Bio-Gate Complete First Phase of Development on Cannabidiol (CBD) and MicroSilver BG™ Based Skin Care Products for Global Commercialization
    Avicanna Announces Results of Annual General Meeting and Provides Corporate Update
    Avicanna Expands The Canadian RHO Phyto Product Offerings With The Addition Of THC-Free High CBD Oral And Sublingual Formulation Across Medical And Adult Use Channels
    Avicanna Announces Mailing of Management Information Circular and Proposed Board Changes
    Avicanna’s Evidence-Based and Dermatologist Tested CBD Derma-Cosmetic Brand Pura Earth™ to be Launched in Adult-Use and Medical Channels Across Canada in Q2 2021.
    Avicanna Makes RHO Phyto™ Medical Cannabis Products Available In Canadian Hospital Pharmacies Through Agreement with Sunnybrook Hospital
    Avicanna Provides Bi-Weekly Update On Status Of Management Cease Trade Order
    Avicanna Announces Initial Listings and Sales for Evidence-Based RHO Phyto™ Products in Canada’s Adult Use Channels Including Ontario, Manitoba, Saskatchewan, and New Brunswick
    Avicanna Announces Receipt of Management Cease Trade Order and Provides Bi-Weekly Status Update
    Avicanna Announces Late Filing of Financial Statements and Application for Management Cease Trade Order
    Avicanna´s Majority Owned Colombian Subsidiary Attains 2021 THC Production Quota and Completes First Commercial Export of Aureus™ Branded THC Active Pharmaceutical Ingredients to Chile